MKP1 regulates the induction of inflammatory response by pneumococcal pneumolysin in human epithelial cells

FEMS Immunology and Medical Microbiology

Volumn 60, Issue 2, 2010, Pages 171-178

  Shin, Hee Sung ^a   Yoo, In Hwa ^a   Kim, Yong Jae ^a   Kim, Hyong Bai ^a   Jin, Shouguang ^b   Ha, Un Hwan ^a  

^a Korea University   (South Korea)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

MKP1; Pneumolysin; Streptococcus pneumoniae; TNF

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PNEUMOLYSIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; EPITHELIUM CELL; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STREPTOCOCCUS PNEUMONIAE;

BACTERIAL PROTEINS; BLOTTING, FAR-WESTERN; CELL LINE; CELL LINE, TUMOR; CYTOKINES; DUAL SPECIFICITY PHOSPHATASE 1; EPITHELIAL CELLS; HELA CELLS; HUMANS; INFLAMMATION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PNEUMOCOCCAL INFECTIONS; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE FACTORS;

EID: 78650375805     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2010.00733.x     Document Type: Article

References (42)

1. Avery OT, MacLeod CM & McCarty M (1979) Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Inductions of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J Exp Med 149: 297-326.
2. Benton KA, Everson MP & Briles DE (1995) A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice. Infect Immun 63: 448-455.
3. Berry AM, Yother J, Briles DE, Hansman D & Paton JC (1989) Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect Immun 57: 2037-2042.
4. Bluestone CD, Stephenson JS & Martin LM (1992) Ten-year review of otitis media pathogens. Pediatr Infect Dis J 11: S7-S11.
5. Braun JS, Novak R, Gao G, Murray PJ & Shenep JL (1999) Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages. Infect Immun 67: 3750-3756.
6. Briles DE, Crain MJ, Gray BM, Forman C & Yother J (1992) Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun 60: 111-116.
7. Bueno OF, De Windt LJ, Lim HW, Tymitz KM, Witt SA, Kimball TR & Molkentin JD (2001) The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo. Circ Res 88: 88-96.
8. Camps M, Nichols A & Arkinstall S (2000) Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J 14: 6-16.
9. Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, Bennett AM & Flavell RA (2006) Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. P Natl Acad Sci USA 103: 2274-2279.
10. Cockeran R, Theron AJ, Steel HC, Matlola NM, Mitchell TJ, Feldman C & Anderson R (2001) Proinflammatory interactions of pneumolysin with human neutrophils. J Infect Dis 183: 604-611.
11. Dinarello CA (2000) Proinflammatory cytokines. Chest 118: 503-508.
12. Ferrante A, Rowan-Kelly B & Paton JC (1984) Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin. Infect Immun 46: 585-589.
13. Franklin CC & Kraft AS (1997) Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J Biol Chem 272: 16917-16923.
14. Gilbert RJ, Jimenez JL, Chen S et al. (1999) Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae. Cell 97: 647-655.
15. Ha U, Lim JH, Jono H et al. (2007) A novel role for IkappaB kinase (IKK) alpha and IKKbeta in ERK-dependent up-regulation of MUC5AC mucin transcription by Streptococcus pneumoniae. J Immunol 178: 1736-1747.
16. Ha UH, Lim JH, Kim HJ, Wu W, Jin S, Xu H & Li JD (2008) MKP1 regulates the induction of MUC5AC mucin by Streptococcus pneumoniae pneumolysin by inhibiting the PAK4-JNK signaling pathway. J Biol Chem 283: 30624-30631.
17. Henderson B, Poole S & Wilson M (1996) Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 60: 316-341.
18. Hersh D, Weiss J & Zychlinsky A (1998) How bacteria initiate inflammation: aspects of the emerging story. Curr Opin Microbiol 1: 43-48.
19. Hutter D, Chen P, Barnes J & Liu Y (2000) Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation. Biochem J 352: 155-163.
20. Jin W, Reiley WR, Lee AJ, Wright A, Wu X, Zhang M & Sun SC (2007) Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells. J Biol Chem 282: 15884-15893.
21. Keyse SM (2000) Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol 12: 186-192.
22. Keyse SM & Emslie EA (1992) Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature 359: 644-647.
23. Koga T, Lim JH, Jono H et al. (2008) Tumor suppressor cylindromatosis acts as a negative regulator for Streptococcus pneumoniae-induced NFAT signaling. J Biol Chem 283: 12546-12554.
24. Lagoa CE, Vodovotz Y, Stolz DB et al. (2005) The role of hepatic type 1 plasminogen activator inhibitor (PAI-1) during murine hemorrhagic shock. Hepatology 42: 390-399.
25. Li Q, Lu Q, Hwang JY, Buscher D, Lee KF, Izpisua-Belmonte JC & Verma IM (1999) IKK1-deficient mice exhibit abnormal development of skin and skeleton. Gene Dev 13: 1322-1328.
26. Li Q, Estepa G, Memet S, Israel A & Verma IM (2000) Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. Gene Dev 14: 1729-1733.
27. Lim JH, Jono H, Koga T et al. (2007a) Tumor suppressor CYLD acts as a negative regulator for non-typeable Haemophilus influenzae-induced inflammation in the middle ear and lung of mice. PLoS One 2: e1032.
28. Lim JH, Stirling B, Derry J et al. (2007b) Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. Immunity 27: 349-360.
29. Mitchell TJ & Andrew PW (1997) Biological properties of pneumolysin. Microb Drug Resist 3: 19-26.
30. Mitchell TJ, Andrew PW, Saunders FK, Smith AN & Boulnois GJ (1991) Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol Microbiol 5: 1883-1888.
31. Murphy TF (2006) The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Curr Opin Infect Dis 19: 225-230.
32. Paton JC (1996) The contribution of pneumolysin to the pathogenicity of Streptococcus pneumoniae. Trends Microbiol 4: 103-106.
33. Paton JC & Ferrante A (1983) Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infect Immun 41: 1212-1216.
34. Paton JC, Rowan-Kelly B & Ferrante A (1984) Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun 43: 1085-1087.
35. Reiley WW, Zhang M, Jin W, Losiewicz M, Donohue KB, Norbury CC & Sun SC (2006) Regulation of T cell development by the deubiquitinating enzyme CYLD. Nat Immunol 7: 411-417.
36. Salojin KV, Owusu IB, Millerchip KA, Potter M, Platt KA & Oravecz T (2006) Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol 176: 1899-1907.
37. Shin HS, Yoo IH, Kim YJ, Lee JY, Kim HB, Jin S & Ha UH (2010) MKP1 regulates the induction of MCP1 by Streptococcus pneumoniae pneumolysin in human epithelial cells. Mol Cells 30: 263-270.
38. Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A & Mosialos G (2003) CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424: 793-796.
39. Ware LB, Bastarache JA & Wang L (2005) Coagulation and fibrinolysis in human acute lung injury - new therapeutic targets? Keio J Med 54: 142-149.
40. Wheeler J, Freeman R, Steward M et al. (1999) Detection of pneumolysin in sputum. J Med Microbiol 48: 863-866.
41. Yang F, Tang E, Guan K & Wang CY (2003) IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J Immunol 170: 5630-5635.
42. Yoo IH, Shin HS, Kim YJ, Kim HB, Jin S & Ha UH (2010) Role of pneumococcal pneumolysin in the induction of inflammatory response in human epithelial cells. FEMS Immunol Med Mic 60: 28-35.